Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer
Clinical trial NCT03938337 · TERMINATED
Trial details
- NCT number
- NCT03938337
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2020-04-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.